Jump to ContentJump to Main Navigation
An Insider’s Guide to Clinical Trials$
Users without a subscription are not able to see the full content.

Curtis L Meinert

Print publication date: 2011

Print ISBN-13: 9780199742967

Published to Oxford Scholarship Online: September 2011

DOI: 10.1093/acprof:oso/9780199742967.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (www.oxfordscholarship.com). (c) Copyright Oxford University Press, 2019. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a monograph in OSO for personal use (for details see www.oxfordscholarship.com/page/privacy-policy).date: 25 June 2019

Biostatistics 101

Biostatistics 101

Chapter:
(p.137) 16 Biostatistics 101
Source:
An Insider’s Guide to Clinical Trials
Author(s):

Curtis L. Meinert

Publisher:
Oxford University Press
DOI:10.1093/acprof:oso/9780199742967.003.0016

This chapter provides a refresher on biostatistics, specific to clinical trials, and a glossary of terms and definitions relevant to the analyses of clinical trials. The question, in the class of trials considered here (superiority, randomized phase III or IV trials with parallel-treatment designs), is whether the results are sufficient to conclude that the test treatment is superior to the comparison control treatment. The approach in addressing the question depends on the school of thought guiding the analysis, broadly: Bayesian, likelihood, and frequentist.

Keywords:   clinical trial, biostatistics, statistical terms, test treatment

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .